This patent teaches that the clinically used cytokine FGF-1 is able to expand bone marrow stromal cells. This bone marrow stromal cell subtype seems to resemble, at least superficially, the mesenchymal stem cell. This is an interesting question that should be examined further.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.